| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP,General Counsel, Secretary | EVP &General Counsel
1 company
Kim Austin D. is an EVP,General Counsel, Secretary at ACADIA PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $1.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2021 | ACAD Acadia Pharmaceuticals Inc | EVP &General Counsel | Sell | 2,107 | $50.61 | $106,635.27 | -17.5% | -62.2% | -54.0% | |
| Jan 6, 2021 | ACAD Acadia Pharmaceuticals Inc | EVP &General Counsel | Sale+OE | 678 | $53.34 | $36,164.52 | -10.9% | - | - | |
| Oct 27, 2020 | ACAD Acadia Pharmaceuticals Inc | EVP &General Counsel | Sale+OE | 8,750 | $45.10 | $394,636.38 | -69.4% | - | - | |
| Apr 30, 2020 | ACAD Acadia Pharmaceuticals Inc | EVP &General Counsel | Sale+OE | 1,072 | $49.22 | $52,763.84 | -30.5% | - | - | |
| Dec 11, 2019 | ACAD Acadia Pharmaceuticals Inc | EVP &General Counsel | Sale+OE | 17,500 | $45.06 | $788,576.25 | -97.2% | - | - |